Back to Search Start Over

PARP-1 regulation of DNA repair factor availability

Authors :
Edouard J. Trabulsi
Karen E. Knudsen
Costas D. Lallas
Christopher McNair
Benjamin E. Leiby
Nicolas Gordon
Amy C. Mandigo
Matthew J. Schiewer
Source :
Journal of Clinical Oncology. 37:269-269
Publication Year :
2019
Publisher :
American Society of Clinical Oncology (ASCO), 2019.

Abstract

269 Background: PARP-1 holds major functions on chromatin, DNA damage repair and transcriptional regulation, both of which are relevant in the context of cancer. Previously, it was determined that PARP-1 ins involved in regulation of androgen receptor activity. Methods: Here, unbiased transcriptional profiling revealed the downstream transcriptional profile of PARP-1 enzymatic activity.Results: Further investigation of the PARP-1-regulated transcriptome and secondary strategies for assessing PARP-1 activity in patient tissues revealed that PARP-1 activity was unexpectedly enriched as a function of disease progression and was associated with poor outcome independent of DNA double-strand breaks, suggesting that enhanced PARP-1 activity may promote aggressive phenotypes. Mechanistic investigation revealed that active PARP-1 served to enhance E2F1 transcription factor activity, and specifically promoted E2F1-mediated induction of DNA repair factors involved in homologous recombination (HR). Conversely, PARP-1 inhibition reduced HR factor availability and thus acted to induce or enhance “BRCA-ness”. Conclusions: These observations bring new understanding of PARP-1 function in cancer and have significant ramifications on predicting PARP-1 inhibitor function in the clinical setting.

Details

ISSN :
15277755 and 0732183X
Volume :
37
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........de2b41b504acbe52dbd2275e0c677dad
Full Text :
https://doi.org/10.1200/jco.2019.37.7_suppl.269